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Despite global efforts to reduce preventable 
maternal and neonatal mortality, between 
5,000 and 6,000 maternal deaths occur 
each year in Bangladesh. Pre-eclampsia and 
eclampsia (PE/E) cause 20% of these deaths.
Maternal and newborn deaths due to PE/E are preventable, yet 
in Bangladesh PE/E is the second most common direct cause of 
maternal mortality, after post-partum hemorrhage (PPH). 
To appreciate the enormity of this problem, at national and 
district levels, in 2015 the Population Council conducted a 
landscape analysis in four districts to: 
• Understand the volume of PE/E research in the last 15 
years; 
• Know the degree of programmatic and policy support for 
PE/E prevention and treatment;
• Analyze the gaps in providers’ knowledge and competence 
for preventing, detecting, and managing PE/E;
• Determine primary health care (PHC) facilities’ capacities to 
manage PE/E;
• Assess community awareness, beliefs, and experiences 
around PE/E; and
• Determine priority areas for PE/E research and 
programmatic interventions.
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PRE-ECLAMPSIA/ECLAMPSIA
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PE/E IN BRIEF
• Pre-eclampsia is a condition               
in pregnant women marked by an 
increase in blood pressure and 
protein in urine after 20 weeks 
gestation.
• Providing high quality antenatal care 
improves the prevention and early 
detection of pre-eclampsia and can 
prevent its progression to eclampsia.
• Eclampsia is a life-threatening 
condition characterized by 
convulsions in women with PE.
• Women in developing countries are 
300 times more likely to die from 
eclampsia than women in developed 
countries.
• Prescribing low-dose aspirin and 
calcium to at-risk women can prevent 
pre-eclampsia and eclampsia.
• Pre-eclampsia and eclampsia can 
be managed by administering anti-
hypertensive drugs and magnesium 
sulphate (MgSO4).
• MgSO4 is the safest and most 
effective treatment for severe PE/E, 
and is one of 13 UN Life-Saving 
Commodities for Women and 
Children. 
• PE/E and other hypertensive 
disorders in pregnancy increase the 
risk of pre-term births, which can 
lead to low birth weight, anemia, and 
stunting.
• Improved prevention, increased 
detection, and effective treatment 
of PE/E can prevent unnecessary 
maternal and newborn deaths.
The Ending Eclampsia project seeks to expand access                
to proven, underutilized interventions and commodities             
for the prevention, early detection, and treatment of pre-
eclampsia and eclampsia and strengthen global partnerships.                
Made possible by the generous support of the 
American people through the United States Agency for 
International Development (USAID).
        For more information, visit endingeclampsia.org.
SERVICE PROVIDER 
KNOWLEDGE AND SKILLS
Researchers interviewed 289 service providers from 134 
facilities, 79 doctors and 210 other service providers. 
Exploring their knowledge, attitudes, and practices 
regarding maternal health, but specifically PE/E, was 
vital for  understanding the gaps that need attention. 
Results showed that 84% of doctors and 79% of 
other service providers were able to correctly define 
hypertension as systolic blood pressure of ≥140 mmHg 
and/or diastolic blood pressure of ≥90 mmHg. Despite 
this, 17% of doctors and 22% of service providers 
are confused about the definition of hypertension. 
Researchers asked service providers to identify 
signs and symptoms of pre-eclampsia, severe pre-
eclampsia and eclampsia. Results showed that doctors 
know, and other service providers had reasonably 
good knowledge, of the signs and symptoms. 
Figure 1 shows correct responses from providers. 
To prevent pre-eclampsia from progressing to 
eclampsia, service providers must know which 
antihypertensive drugs to use and when to initiate 
treatment. When a patient experiences convulsions 
due to eclampsia, providers should also know which 
anticonvulsants, such as MgSO4, to administer and 
how to monitor, identify, and prescribe calcium 
gluconate for any MgSO4 toxicity, if necessary. 
Researchers asked providers about commonly used 
antihypertensive drugs for managing mild to moderate 
hypertension and severe hypertension in pregnancy, as 
well as when to initiate treatment for these conditions. 
The drug of choice is labetalol, but it is expensive 
and not widely available. Methyldopa or nifedipine 
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FIGURE 1.   KNOWLEDGE OF SIGNS AND 
SYMPTOMS OF PRE-ECLAMPSIA (%) 
NATIONAL POLICY 
AWARENESS 
The Bangladesh government’s policy on PE/E falls 
under the broader realm of maternal health, with 
Standard Operating Procedures specifying prevention 
and management of PE/E at secondary and tertiary 
facilities. The government has yet to formalize any 
policy on PE/E prevention and management at primary 
facilities. A protocol has been developed, tested, and 
approved for implementation in the field, but it has not 
been widely circulated.  
There is confusion among policy makers and program 
managers about PE/E prevention and treatment 
policies. A majority of them informed Council 
researchers they not aware of any policy addressing 
PE/E, nor do they have copies of it, or written 
instructions. 
In fact, only 27% of doctors and 3% of other providers, 
which include nurses/midwives, family welfare visitors 
(FWVs), and sub-assistant community medical officers 
(SACMOs), know of any such guidelines. 
One respondent said:
“I don’t know about the 
government policy. There might 
be one. I cannot tell you about the 
policy, as I didn’t get it yet. I didn’t 
get the policy in my hand, so I don’t 
know about where the policy is 
being implemented. There is no 
implementation policy in my district 
or upazilas.” 
Policy maker and program 
manager, Ministry of Health and 
Family Welfare 
All district hospitals  reported availability of guidelines 
or protocols, but only 50% of maternal and child welfare 
centers (MCWCs) and 36% of upazila health complexes 
(UHCs) have the same. As expected, no union health 
and family welfare center (UH&FWC) has any guidelines 
or protocols for diagnosing and managing PE/E. 
Researchers found a similar situation for guidelines 
or protocols on the administration of MgSO4; no 
written guidelines or protocol exists in any center.
are the next best drugs for this use, and hydralazine 
is best for severe hypertension in pregnancy. Only 
77% of doctors and 19% of other service providers 
mentioned methyldopa or nifedipine as their drugs of 
choice for managing mild to moderate hypertension 
in pregnancy. For severe hypertension, 9% of doctors, 
and no other service providers, mentioned hydralazine. 
Only 19% percent of doctors and 9% of other service 
providers correctly knew when to initiate hydralazine.
During antenatal care (ANC) consultations, only 1.87% 
of providers looked for PE risk factors. About 4% 
advised women of symptoms for impending eclampsia, 
and 8% of secondary facility providers and 1% from 
primary facilities described pre-eclampsia detection, 
which explains the low detection of PE/E patients 
by primary and secondary facility providers during 
ANC and postnatal care (PNC) consultations. This 
supports evidence that shows service providers’ lack 
of knowledge, skills, low confidence, poor logistical 
support, and reluctance among lower cadre providers.
FACILITY CAPACITY AND 
PREPAREDNESS  
For effective and timely treatement, it is essential that 
certain equipment and commodities are available at 
facilities. MgSO4 was found in four secondary facilities, 
but in no UH&FWCs. Four secondary facilities reported 
its regular use, while seven reported occasional use. 
Calcium gluconate for managing MgSO4 toxicity was 
found in only one secondary facility, but not in any 
primary facilities. 
It is important to note that 75% of MCWCs and 45% of 
secondary facilities never used MgSO4. Those who do 
administer MgSO4 use it in varying concentrations, from 
20% solution, to 4% water/volume, to 50% solution, 
while some did not know which concentration they use. 
Of the facilities that use MgSO4, 55% get it from the 
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central level regularly or purchase it from local markets. 
The remaining 45% said patients purchase it from 
markets when needed.
Researchers asked informants from facilities if service 
providers had the necessary skills for providing 
Emergency Obstetric and Neonatal Care, which include 
the capacity to administer prenatal antibiotics, oxytocin, 
and anticonvulsants, as well as blood transfusions, 
caesarian sections, and neonatal resuscitation. 
Researchers also asked if these procedures occurred 
within the last three months. Findings suggest not all 
elements are available in all secondary facilities, and 
many did not occur in the last three months. 
All facility informants were asked if they have certain 
regular and emergency response materials in their 
facilitiy, particularly those for PE/E services. Almost all 
secondary facilities reported regular and emergency 
response materials. 
Primary facilities, however, are not designed to 
provide emergency care, and some facilities have the 
materials in variable quantities. Thirteen centers have 
20 milliliter syringes, none  had 6mg betamethasone/
dexamethasone for premature respiratory distress 
syndrome (PRDS), and 15 primary facilities had none 
of the regular and emergency response materials. 
Interestingly, 61% and 86% of primary facilities 
had misoprostol for PPH prevention and neonatal 
resuscitation kits, respectively. 
See Figure 3 for details on the availability of emergency 
response at facilities. 
 
FIGURE 2. SERVICE PROVIDER KNOWLEDGE 
OF PROPHYLACTIC DRUG USE FOR PE/E 
INTERVENTION (%) 
FIGURE 3. AVAILABILITY OF EMERGENCY 
RESPONSE SUPPLIES AT FACILITIES 
COMMUNITY KNOWLEDGE 
AND PERCEPTIONS
To assess community PE/E awareness, beliefs, 
and experiences, and strategies for seeking care, 
researchers investigated community perspectives in 
male and female focus group discussions and in-depth 
interviews with PE/E survivors and their families. 
Despite some similarities, there were major disparities 
between female and male informants about the serious 
problems women suffer during and after delivery. 
Female participants said the most serious problems 
during pregnancy and immediately following childbirth 
are excessive bleeding, convulsion, anemia, abdominal 
pain, physical weakness, malnutrition, retained 
placenta, ruptured uterus, and fetal presentation other 
than head first. 
Male informants reported anemia, physical weakness, 
leucorrhea (discharge), loss of appetite, headache, 
edema, retained placenta, and bleeding from the vagina 
as the most serious problems. Both men and women 
report that mothers-in-law are best equipped to make 
decisions when a women experiences complications.
 “These are women’s problems 
during pregnancy and after 
delivery. My mother also passed 
through these. So, I don’t want to 
interfere with women’s problems 
and step in. My mother and 
grandmother might be the right 
persons to decide.” Male, FGD 
While one female respondent said: 
“The mothers of our community 
think these are general problems 
during pregnancy and delivery and 
they also passed through these. So, 
they don’t give much importance 
on the problems, rather suggest 
some spiritual and common sense 
remedies.” Female, FGD 
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RECOMMENDATIONS
• Develop policy for primary and secondary facilities 
to implement uniform clinical practice of PE/E 
prevention and management; 
• Trainings for all health providers according to new 
policy;  
• Distribute official policy guidelines throughout the 
health system; 
• Review and revise curricula for nurses, midwives, 
FWVs, SACMOs, and paramedics;
• All levels of service providers should be properly 
trained on broader maternal and newborn 
health issues, particularly PE/E, to build their 
confidence and skills for its prevention, detection, 
and management. Training should also include 
emergency management of premature births and 
referrals to higher level facilities; 
• ANC, delivery, and PNC service providers should 
screen every patient for increased blood pressure 
and assess PE/E risk;
• PE/E training for field workers, supervisors, and 
program managers should create more awareness 
within communities about the importance of ANC 
and PNC care, and signs and symptoms of PE/E;  
• Essential emergency materials need to be available 
in all facilities, with regular monitoring from district 
program managers; and 
• Referral system strengthening. 
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